47 results on '"Bohra, S"'
Search Results
2. Stress behavior and biochemical profiling of Opsarius bendelisis under different photoperiods.
- Author
-
Chand, J., Karki, N. S., Bhatt, J., Bohra, S., and Pathak, B. C.
- Published
- 2024
- Full Text
- View/download PDF
3. Irish society of gastroenterology: Proceedings of meeting held Friday 12th and Saturday 13th June, 1998
- Author
-
Ryan, B. M., McKiernan, S., Keeling, P. W. N., Byrne, P. J., Quill, R., McCallion, K., Mitchell, R. M. S., Watson, R. G. P., Collins, J. S. A., Gardiner, K. R., Winter, D. C., O’Sullivan, G. C., Taylor, C. T., Fanning, N. F., Redmond, H. P., O’Donoghue, D. P., Baird, A. W., Harvey, B. J., Brannigan, A. E., O’Connell, P. R., Regan, M. C., Fitzpatrick, J. M., Watson, R. W. G., Lemass, H., Ryan, E., MacMathuna, P., Crowe, J., O’Keane, J. C., Goh, J., MacMathuna, P., Baird, A., Maher, L., Godson, C., Brady, H. R., Petasis, N. A., Fokin, V. V., O’Keane, J. C., Barry, M. K., Grant, D. C., Sheahan, K., O’Donoghue, D. P., Hyland, J. M. P., Sheehan, K. M., Sheahan, K., O’Donoghue, D. P., Fitzgerald, D. J., Murray, F. E., Heaney, A., Collins, J. S. A., Bamford, K. B., Watson, R. G. P., McFarland, R. J., Tham, T. C. K., McNamara, D., Franelli, S., Whelan, H., Hamilton, H., Beattie, S., O’Morain, C., Ryan, B. M., Keeling, P. W. N., Brennan, E. G., O’Hare, N., McDermott, R., Byrne, P. J., McDougall, N. I., Collins, J. S. A., Gieeson, C. M., Russell, S. E. H., Sloan, J. M., Morrisey, D., Murphy, L., Kiely, B., Fitzgerald, G., Daly, C., O’Sullivan, G., Shanahan, F., Collins, J. K., Marteau, P., Johnston, S. D., Watson, R. G. P., Coates, C., Feighery, C., O’Keeffe, J., Whelan, A., Lynch, S., Weir, D. G., Abuzakouk, M., Feighery, C., Barnes, L., O’Gorman, N., McKenna, M., Freaney, R., Young, M., Gaines, S., Brady, D., Drudy, D., O’Farrelly, C., Gilleece, A., Fenelon, L., McPartlin, J., Goh, J., MacMathuna, P., Baird, A., Godson, C., Brady, H. R., Petasis, N. A., Fokin, V. V., Hopkins, A. M., Myers, A., Moynagh, P., Baird, A. W., O’Donoghue, D. P., Kirby, J. M., Tham, T. C. K., Allen, M. J., Best, B., Calvert, H., Kirk, S., McKelvey, S. T. D., Moorehead, R. J., Varghese, J. C., Sookhai, S., Murray, F. E., Walsh, T., Osborne, H., Broe, P., Lee, M. J., Moriarty, D., Baird, A. W., Watson, R. W. G., Brannigan, A. E., Coffey, R., Murphy, E., Fitzpatrick, J. M., Shah, A. A., Murray, F. E., Murray, E., Thjodleifsson, B., Bjarnason, I., Fitzgerald, D. J., Sheehan, K. M., Murray, E., Shah, A. A., Murray, F. E., Thjodleifsson, B., Bjarnason, I., Fitzgerald, D. J., Montague, S., McNamara, D., Forkin, C., O’Morain, C., O’Toole, G. C., Grant, D. C., Barry, M. K., Sheahan, K., O’Donoghue, D. P., Hyland, J. M. P., Gallagher, C. M., Grant, D. C., Connell, P., Barry, M. K., Traynor, O., Hyland, J. M. P., Barry, M. K., Grant, D. C., Sheahan, K., O’Donoghue, D. P., Hyland, J. M. P., Ling, T. C., Johnston, B., Byrne, M. F., Farrell, M. A., Varghese, J. C., Lee, M. J., Murray, F. E., Goulding, C. A., Albloushi, S. S., O’Connell, P., Murray, F. E., Graham, L. E., Robinson, T. J., Graham, L. E., Robinson, T. J., Jabeen, T., Cannon, B., Jenkins, D., Whelton, M. J., Bohra, S., Cannon, B., Whelton, M. J., Keohane, C., Duggan, M., Bohra, S., Cannon, B., Whelton, M. J., Siddheshwar, R. K., Wilson, R. G., Hainsworth, P. J., Campbell, F. C., Kelly, S. B., Kirby, J. M., Tham, T. C. K., Best, B., Calvert, H., Moorehead, R. J., Kirk, S., Heaney, A., Collins, J. S. A., Watson, R. G. P., Heaney, A., Collins, J. S. A., Watson, R. G. P., Bamford, K. B., McFarland, R. J., Tham, T. C. K., Egan, B. M., Grant, D. C., Barry, M. K., Traynor, O., Hyland, J. M. P., Simutowe, C., McNamara, D. A., Collins, N., Walsh, T. N., Mukherjee, A., Scott, M., Pohl, C., Duggan, E., Wasi, M., Sarkar, A., Donnell, L. O., Eustace, P. W., Johnston, J. G., Waldron, R., Barrett, S., Ryan, E., MacMathuna, P., Crowe, J., Callagy, G., Keane, J. C. O., Coughlan, B., Crowe, J., Sheehan, J., Hickey, A., Carr, A., Kell, M. R., Lynch, M., Ryan, D., Winter, D. C., Rajpal, P., Kirwan, W. O., Redmond, H. P., Larkin, C. J., Sloan, J. M., Watson, R. G. P., Ardill, J. E. S., Collins, J. S. A., Buchanan, K. D., Lim, P. L., Gibbons, M., Crawford, E. J., Johnston, B. T., Mitchell, R. M. S., Watson, R. G. P., Gardiner, K. R., Collins, J. S. A., McCallion, K., Mitchell, R. M. S., Collins, J. S. A., Watson, R. G. P., McCallion, K., Gardiner, K. R., McCallion, K., Gardiner, K. R., Mitchell, R. M. S., Watson, R. G. P., Collins, J. S. A., Rodgers, C., Johnston, S., Watson, R. G. P., Crone, B. M., Love, A. H. G., Feighery, L., Feighery, C., Jackson, J., Abuzakouk, M., Lynch, S., Weir, D. G., Yassin, M. M. I., Harkin, D. W., Barros D’sa, A. A. B., Parks, T. G., Curry, M. P., Hegarty, J. E., Golden-Mason, L., O’Farrelly, C., Hannigan, E., and Parfrey, N.
- Published
- 1998
- Full Text
- View/download PDF
4. Lung Cancer Disease Diagnosis Using Machine Learning Approach
- Author
-
Mukherjee, Swati, primary and Bohra, S. U., additional
- Published
- 2020
- Full Text
- View/download PDF
5. Chiral ligand exchange chromatography on polygalactomannan (Guaran)
- Author
-
Mathur, R., Bohra, S., Mathur, V., Narang, C. K., and Mathur, N. K.
- Published
- 1992
- Full Text
- View/download PDF
6. Integrated Steering Systems to Enhance Manoeuvrability: Technical Note
- Author
-
Palanivendhan, M., primary, Banwar, U., additional, Vyas, S., additional, and Bohra, S., additional
- Published
- 2018
- Full Text
- View/download PDF
7. Entropy Generation on MHD Slip Flow Over a Stretching Cylinder with Heat Generation/Absorption
- Author
-
Jain, S., primary and Bohra, S., additional
- Published
- 2018
- Full Text
- View/download PDF
8. REGENERATION OF SHOOT BUDS FROM CALLUS CULTURES OF PAPAVER SOMNIFERUM
- Author
-
SWARANKAR, P. L. and BOHRA, S. P.
- Published
- 1989
9. BIOCHEMICAL CHANGES DURING ANDROGENESIS IN DATURA INNOXIA
- Author
-
SWARNKAR, P. L., BOHRA, S. P., and CHANDRA, N.
- Published
- 1987
10. α-AMYLASE ACTIVITY AND MORPHOGENETIC POTENTIAL IN CALLUS CULTURES OF SOLANUM SURATTENSE
- Author
-
SWARNKAR, P. L., BOHRA, S. P., and CHANDRA, N.
- Published
- 1987
11. Lettuce Seed Germination : Reversal of Salinity Induced Inhibition by Ethylene
- Author
-
Verma, C. M., Bohra, S. P., and Sankhla, N.
- Published
- 1973
12. Fenofibrate intervention and event lowering in diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
- Author
-
Scott, R, Best, J, Forder, P, Taskinen, M-R, Simes, J, Barter, P, Keech, A, Colman, P, D'Emden, M, Davis, T, Drury, P, Ehnholm, C, Glasziou, P, Hunt, D, Kesaniemi, YA, Laakso, M, Simes, RJ, Sullivan, D, Whiting, M, Ansquer, J-C, Fraitag, B, Anderson, N, Hankey, G, Lehto, S, Mann, S, Romo, M, Li, LP, Hennekens, C, MacMahon, S, Pocock, S, Tonkin, A, Wilhelmsen, L, Akauola, H, Alford, F, Beinart, I, Bohra, S, Boyages, S, Connor, H, Darnell, D, Davoren, P, Lepre, F, De Looze, F, Duffield, A, Fassett, R, Flack, J, Fulcher, G, Grant, S, Hamwood, S, Harmelin, D, Jackson, R, Jeffries, W, Kamp, M, Kritharides, L, Mahar, L, McCann, V, McIntyre, D, Moses, R, Newnham, H, Nicholson, G, O'Brien, R, Park, K, Petrovsky, N, Phillips, P, Pinn, G, Simmons, D, Stanton, K, Stuckey, B, Sullivan, DR, Suranyi, M, Suthers, M, Tan, Y, Templer, M, Topliss, D, Waites, JH, Watts, G, Welborn, T, Wyndham, R, Haapamaki, H, Kesaniemi, A, Lahtela, J, Levanen, H, Saltevo, J, Sodervik, H, Taskinen, M, Vanhala, M, Baker, J, Burton, A, Dixon, P, Doran, J, Dunn, P, Graham, N, Hamer, A, Hedley, J, Lloyd, J, Manning, P, McPherson, I, Morris, S, Renner, C, Smith, R, Wackrow, M, Young, S, Alard, F, Alcoe, J, Allan, C, Amerena, J, Anderson, R, Arnold, N, Arsov, T, Ashby, D, Atkinson, C, Badhni, L, Balme, M, Barton, D, Batrouney, B, Beare, C, Beattie, T, Beggs, J, Bendall, C, Benz, A, Bond, A, Bradfield, R, Bradshaw, J, Brearley, S, Bruce, D, Burgess, J, Butler, J, Callary, M, Campbell, J, Chambers, K, Chow, J, Chow, S, Ciszek, K, Clifton, P, Clifton-Bligh, P, Clowes, V, Coates, P, Cocks, C, Cole, S, Colquhoun, D, Correcha, M, Costa, B, Coverdale, S, Croft, M, Crowe, J, Dal Sasso, S, Davis, W, Dunn, J, Edwards, S, Elder, R, El-Kaissi, S, Emery, L, England, M, Farouque, O, Fernandez, M, Fitzpatrick, B, Francis, N, Freeman, P, Fuller, A, Gale, D, Gaylard, V, Gillzan, C, Glatthaar, C, Goddard, J, Grange, V, Greenaway, T, Griffin, J, Grogan, A, Guha, S, Gustafson, J, Hamblin, PS, Hannay, T, Hardie, C, Harper, A, Hartl, G, Harvey, A, Havlin, S, Haworth, K, Hay, P, Hay, L, Heenan, B, Hesketh, R, Heyworth, A, Hines, M, Hockings, G, Hodge, A, Hoffman, L, Hoskin, L, Howells, M, Hunt, A, Inder, W, Jackson, D, Jovanovska, A, Kearins, K, Kee, P, Keen, J, Kilpatrick, D, Kindellan, J, Kingston-Ray, M, Kotowicz, M, Lassig, A, Layton, M, Lean, S, Lim, E, Long, F, Lucas, L, Ludeman, D, Ludeman-Robertson, C, Lyall, M, Lynch, L, Maddison, C, Malkus, B, Marangou, A, Margrie, F, Matthiesson, K, Matthiesson, J, Maxwell, S, McCarthy, K, McElduff, A, Mckee, H, McKenzie, J, McLachan, K, McNair, P, Meischke, M, Miller, AMC, Morrison, B, Morton, A, Mossman, W, Mowat, A, Muecke, J, Murie, P, Murray, S, Nadorp, P, Nair, S, Nairn, J, Nankervis, A, Narayan, K, Nattrass, N, Ngui, J, Nicholls, S, Nicholls, V, Nye, JA, Nye, E, O'Neal, D, O'Neill, M, O'Rourke, S, Pearse, J, Pearson, C, Phillips, J, Pittis, L, Playford, D, Porter, L, Portley, R, Powell, M, Preston, C, Pringle, S, Quinn, WA, Raffaele, J, Ramnath, G, Ramsden, J, Richtsteiger, D, Roffe, S, Rosen, S, Ross, G, Ross, Z, Rowe, J, Rumble, D, Ryan, S, Sansom, J, Seymour, C, Shanahan, E, Shelly, S, Shepherd, J, Sherman, G, Siddall, R, Silva, D, Simmons, S, Simpson, R, Sinha, A, Slobodniuk, R, Smith, M, Smith, P, Smith, S, Smith-Orr, V, Snow, J, Socha, L, Stack, T, Steed, K, Steele, K, Stephensen, J, Stevens, P, Stewart, G, Stewart, R, Strakosch, C, Sullivan, M, Sunder, S, Sunderland, J, Tapp, E, Taylor, J, Thorn, D, Tolley, A, Torpy, D, Truran, G, Turner, F, Turner, J, Van de Velde, J, Varley, S, Wallace, J, Walsh, J, Walshe, J, Ward, G, Watson, B, Watson, J, Webb, A, Werner, F, White, E, Whitehouse, A, Whitehouse, N, Wigg, S, Wilkinson, J, Wilmshurst, E, Wilson, D, Wittert, G, Wong, B, Wong, M, Worboys, S, Wright, S, Wu, S, Yarker, J, Yeo, M, Young, K, Youssef, J, Yuen, R, Zeimer, H, Ziffer, RW, Aura, A, Friman, A, Hanninen, J, Henell, J, Hyvarinen, N, Ikonen, M, Itkonen, A, Jappinen, J, Jarva, A, Jerkkola, T, Jokinen, V, Juutilainen, J, Kahkonen, H, Kangas, T, Karttunen, M, Kauranen, P, Kortelainen, S, Koukkunen, H, Kumpulainen, L, Laitinen, T, Laitinen, M, Lehto, R, Leinonen, E, Lindstron-Karjalainen, M, Lumiaho, A, Makela, J, Makinen, K, Mannermaa, L, Mard, T, Miettinen, J, Naatti, V, Paavola, S, Parssinen, N, Ripatti, J, Ruotsalainen, S, Salo, A, Siiskonen, M, Soppela, A, Starck, J, Suonranta, I, Ukkola, L, Valli, K, Virolainen, J, Allan, P, Arnold, W, Bagg, W, Balfour, K, Ball, T, Ballantine, B, Ballantyne, C, Barker, C, Bartley, F, Berry, E, Braatvedt, G, Campbell, A, Clarke, T, Clarke, R, Claydon, A, Clayton, S, Cresswell, P, Cutfield, R, Daffurn, J, Delahunt, J, Dissnayake, A, Eagleton, C, Ferguson, C, Florkowski, C, Fry, D, Giles, P, Gluyas, M, Grant, C, Guile, P, Guolo, M, Hale, P, Hammond, M, Healy, P, Hills, M, Hinge, J, Holland, J, Hyne, B, Ireland, A, Johnstone, A, Jones, S, Kerr, G, Kerr, K, Khant, M, Krebs, J, Law, L, Lydon, B, MacAuley, K, McEwan, R, McGregor, P, McLaren, B, McLeod, L, Medforth, J, Miskimmin, R, Moffat, J, Pickup, M, Prentice, C, Rahman, M, Reda, E, Ross, C, Ryalls, A, Schmid, D, Shergill, N, Snaddon, A, Snell, H, Stevens, L, Waterman, A, Watts, V, Jayne, K, Keirnan, E, Newman, P, Ritchie, G, Rosenfeld, A, Beller, E, Gebski, V, Pillai, A, Anderson, C, Blakesmith, S, Chan, S-Y, Czyniewski, S, Dobbie, A, Doshi, S, Dupuy, A, Eckermann, S, Edwards, M, Fields, N, Flood, K, Ford, S, French, C, Gillies, S, Greig, C, Groshens, M, Gu, J, Guo, Y, Hague, W, Healy, S, Hones, L, Hossain, Z, Howlett, M, Lee, J, Li, L-P, Matthews, T, Micallef, J, Martin, A, Minns, I, Nguyen, A, Papuni, F, Patel, A, Pike, R, Pena, M, Pinto, K, Schipp, D, Schroeder, J, Sim, B, Sodhi, C, Sourjina, T, Sutton, C, Taylor, R, Vlagsma, P, Walder, S, Walker, R, Wong, W, Zhang, J, Zhong, B, Kokkonen, A, Narva, P, Niemi, E-L, Syrjanen, A-M, Lintott, C, Tirimacco, R, Kajosaari, M, Raman, L, Sundvall, J, Tukianen, M, Crimet, D, Sirugue, I, and Aubonnet, P
- Subjects
Male ,Cardiac & Cardiovascular Systems ,Endocrinology, Diabetes and Metabolism ,Atorvastatin ,Coronary Disease ,Fibrate ,SECONDARY PREVENTION ,ATORVASTATIN ,law.invention ,Placebos ,Randomized controlled trial ,Fenofibrate ,law ,Myocardial infarction ,1102 Cardiorespiratory Medicine and Haematology ,Finland ,Original Investigation ,Hypolipidemic Agents ,PLASMA ,CHOLESTEROL ,Middle Aged ,INSULIN ,CARDIOVASCULAR-DISEASE ,Cardiovascular Diseases ,Female ,Cardiology and Cardiovascular Medicine ,Life Sciences & Biomedicine ,medicine.drug ,medicine.medical_specialty ,medicine.drug_class ,Diabetes Complications ,Endocrinology & Metabolism ,Double-Blind Method ,Internal medicine ,Diabetes mellitus ,Intervention (counseling) ,medicine ,Humans ,CORONARY-HEART-DISEASE ,Obesity ,Triglycerides ,Aged ,Apolipoproteins B ,Bezafibrate ,Science & Technology ,business.industry ,Cholesterol, HDL ,Australia ,Cholesterol, LDL ,medicine.disease ,BEZAFIBRATE ,FIELD Study Investigators ,MYOCARDIAL-INFARCTION ,Diabetes Mellitus, Type 2 ,Cardiovascular System & Hematology ,Cardiovascular System & Cardiology ,business ,HIGH-DENSITY-LIPOPROTEIN ,New Zealand - Abstract
Objective The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study is examining the effects of long-term fibrate therapy on coronary heart disease (CHD) event rates in patients with diabetes mellitus. This article describes the trial's run-in phase and patients' baseline characteristics. Research design and methods FIELD is a double-blind, placebo-controlled trial in 63 centres in 3 countries evaluating the effects of fenofibrate versus placebo on CHD morbidity and mortality in 9795 patients with type 2 diabetes mellitus. Patients were to have no indication for lipid-lowering therapy on randomization, but could start these or other drugs at any time after randomization. Follow-up in the study was to be for a median duration of not less than 5 years and until 500 major coronary events (fatal coronary heart disease plus nonfatal myocardial infarction) had occurred. Results About 2100 patients (22%) had some manifestation of cardiovascular disease (CVD) at baseline and thus high risk status. Less than 25% of patients without CVD had a (UKPDS determined) calculated 5-year CHD risk of 30), most were men, two-thirds were aged over 60 years, and substantial proportions had NCEP ATP III features of the metabolic syndrome independent of their diabetes, including low HDL (60%), high blood pressure measurement or treatment for hypertension (84%), high waist measurement (68%), and raised triglycerides (52%). After a 6-week run-in period before randomisation with all participants receiving 200 mg comicronized fenofibrate, there were declines in total and LDL cholesterol (10%) and triglycerides (26%) and an increase in HDL cholesterol (6.5%). Conclusion The study will show the effect of PPAR-alpha agonist action on CHD and other vascular outcomes in patients with type 2 diabetes including substantial numbers with low to moderate CVD risk but with the various components of the metabolic syndrome. The main results of the study will be reported in late 2005.
- Published
- 2005
13. The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
- Author
-
Barter, P, Best, J, Colman, P, d'Emden, M, Davis, T, Drury, P, Ehnholm, C, Glasziou, P, Hunt, D, Keech, A, Laakso, M, Scott, R, Simes, RJ, Sullivan, D, Taskinen, M-R, Whiting, M, Ansquer, J-C, Fraitag, B, Anderson, N, Hankey, G, Lehto, S, Mann, S, Romo, M, Li, LP, Akauola, H, Alford, F, Beinart, I, Bohra, S, Boyages, S, Connor, H, Darnell, D, Davoren, P, Lepre, F, De Looze, D, Duffield, A, Fassett, R, Flack, J, Fulcher, G, Grant, S, Hamwood, S, Harmelin, D, Jackson, R, Jeffries, W, Kamp, M, Kritharides, L, Mahar, L, McCann, V, McIntyre, D, Moses, R, Newnham, H, Nicholson, G, O'Brien, R, Park, K, Petrovsky, N, Phillips, P, Pinn, G, Simmons, D, Stanton, K, Stuckey, B, Sullivan, DR, Suranyi, M, Suthers, M, Tan, Y, Templer, M, Topliss, D, Waites, JH, Watts, G, Welborn, T, Wyndham, R, Haapamaki, H, Kesaniemi, A, Lahtela, J, Levanen, H, Saltevo, J, Sodervik, H, Taskinen, M, and Vanhala, M
- Abstract
Background: Fibrates correct the typical lipid abnormalities of type 2 diabetes mellitus, yet no study, to date, has specifically set out to evaluate the role of fibrate therapy in preventing cardiovascular events in this setting. Methods: Subjects with type 2 diabetes, aged 50-75 years, were screened for eligibility to participate in a long-term trial of comicronized fenofibrate 200 mg daily compared with matching placebo to assess benefits of treatment on the occurrence of coronary and other vascular events. People with total cholesterol levels 3.0-6.5 mmol/L plus either a total-to-HDLc ratio >4.0 or triglyceride level >1.0 mmol /L with no clear indication for lipid-modifying therapy were eligible. Results: A total of 9795 people were randomized into the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial. All received dietary advice, followed by a 6-week single-blind placebo run-in, then a 6-week active run-in period before randomization. Participants are being followed up every 6 months for outcome events and safety assessments. The study is designed to yield at least 500 coronary events (primary endpoint: first nonfatal myocardial infarction or coronary death) over 5 years, to have 80% power to identify as statistically significant at 2P = 0.05 a 22% reduction in such events, using intention-to-treat methods. Conclusions: Type 2 diabetes is the most common endocrine disorder worldwide, and its prevalence is increasing. The current evidence about use of fibrates in type 2 diabetes, from around 2000 people treated, will increase with FIELD to evidence from around 12000. FIELD will establish the role of fenofibrate treatment in reducing cardiovascular risk in people with type 2 diabetes. The main results are expected to be available in late 2005. © 2004 The FIELD Study Investigators; licensee BioMed Central Ltd.
- Published
- 2004
14. Optimization of absorber layers' thickness in a Si micromorph solar cell for current matching with intermediate ZnO reflector
- Author
-
Bohra, S. S., primary and Panchal, A. K., additional
- Published
- 2013
- Full Text
- View/download PDF
15. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: Baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
- Author
-
Keech, AC, Scott, R, Best, J, Forder, P, Taskinen, MR, Simes, J, Barter, P, Colman, P, d'Emden, M, Davis, T, Drury, P, Ehnholm, C, Glasziou, P, Hunt, D, Kesaniemi, YA, Laakso, M, Simes, RJ, Sullivan, D, Whiting, M, Ansquer, JC, Fraitag, B, Anderson, N, Hankey, G, Lehto, S, Mann, S, Romo, M, Li, LP, Hennekens, C, MacMahon, S, Pocock, S, Tonkin, A, Wilhelmsen, L, Akauola, H, Alford, F, Beinart, I, Bohra, S, Boyages, S, Connor, H, Darnell, D, Davoren, P, Lepre, F, De Looze, F, Duffield, A, Fassett, R, Flack, J, Fulcher, G, Grant, S, Hamwood, S, Harmelin, D, Jackson, R, Jeffries, W, Kamp, M, Kritharides, L, Mahar, L, McCann, V, McIntyre, D, Moses, R, Newnham, H, Nicholson, G, O'Brien, R, Park, K, Petrovsky, N, Phillips, P, Pinn, G, Simmons, D, Stanton, K, Stuckey, B, Sullivan, DR, Suranyi, M, Suthers, M, Tan, Y, Templer, M, Topliss, D, Waites, JH, Watts, G, Welborn, T, Wyndham, R, Haapamaki, H, Kesaniemi, A, Lahtela, J, Levanen, H, Saltevo, J, Sodervik, H, Taskinen, M, Vanhala, M, Baker, J, Burton, A, Dixon, P, Doran, J, Dunn, P, Graham, N, Hamer, A, Hedley, J, Lloyd, J, Manning, P, McPherson, I, Morris, S, Keech, AC, Scott, R, Best, J, Forder, P, Taskinen, MR, Simes, J, Barter, P, Colman, P, d'Emden, M, Davis, T, Drury, P, Ehnholm, C, Glasziou, P, Hunt, D, Kesaniemi, YA, Laakso, M, Simes, RJ, Sullivan, D, Whiting, M, Ansquer, JC, Fraitag, B, Anderson, N, Hankey, G, Lehto, S, Mann, S, Romo, M, Li, LP, Hennekens, C, MacMahon, S, Pocock, S, Tonkin, A, Wilhelmsen, L, Akauola, H, Alford, F, Beinart, I, Bohra, S, Boyages, S, Connor, H, Darnell, D, Davoren, P, Lepre, F, De Looze, F, Duffield, A, Fassett, R, Flack, J, Fulcher, G, Grant, S, Hamwood, S, Harmelin, D, Jackson, R, Jeffries, W, Kamp, M, Kritharides, L, Mahar, L, McCann, V, McIntyre, D, Moses, R, Newnham, H, Nicholson, G, O'Brien, R, Park, K, Petrovsky, N, Phillips, P, Pinn, G, Simmons, D, Stanton, K, Stuckey, B, Sullivan, DR, Suranyi, M, Suthers, M, Tan, Y, Templer, M, Topliss, D, Waites, JH, Watts, G, Welborn, T, Wyndham, R, Haapamaki, H, Kesaniemi, A, Lahtela, J, Levanen, H, Saltevo, J, Sodervik, H, Taskinen, M, Vanhala, M, Baker, J, Burton, A, Dixon, P, Doran, J, Dunn, P, Graham, N, Hamer, A, Hedley, J, Lloyd, J, Manning, P, McPherson, I, and Morris, S
- Abstract
Objective: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study is examining the effects of long-term fibrate therapy on coronary heart disease (CHD) event rates in patients with diabetes mellitus. This article describes the trial's run-in phase and patients' baseline characteristics. Research design and methods: FIELD is a double-blind, placebo-controlled trial in 63 centres in 3 countries evaluating the effects of fenofibrate versus placebo on CHD morbidity and mortality in 9795 patients with type 2 diabetes mellitus. Patients were to have no indication for lipid-lowering therapy on randomization, but could start these or other drugs at any time after randomization. Follow-up in the study was to be for a median duration of not less than 5 years and until 500 major coronary events (fatal coronary heart disease plus nonfatal myocardial infarction) had occurred. Results: About 2100 patients (22%) had some manifestation of cardiovascular disease (CVD) at baseline and thus high risk status. Less than 25% of patients without CVD had a (UKPDS determined) calculated 5-year CHD risk of <5%, but nearly all had a 5-year stroke risk of <10%. Despite this, half of the cohort were obese (BMI >30), most were men, two-thirds were aged over 60 years, and substantial proportions had NCEP ATP III features of the metabolic syndrome independent of their diabetes, including low HDL (60%), high blood pressure measurement (41%), high waist measurement (65%), and raised triglycerides (52%). After a 6-week run-in period before randomisation with all participants receiving 200 mg comicronized fenofibrate, there were declines in total and LDL cholesterol (10%) and triglycerides (26%) and an increase in HDL cholesterol (6.5%). Conclusion: The study will show the effect of PPAR-alpha agonist action on CHD and other vascular outcomes in patients with type 2 diabetes including substantial numbers with low to moderate CVD risk but with the various components of the metabolic
- Published
- 2005
16. Prevalence of ICD and/or CRT Device Therapy in HF Patients: Interim Results of an Australian Multicentre Study
- Author
-
Driscoll, A., primary, Elsik, M., additional, Reid, C., additional, Heynen, H., additional, Hare, D.L., additional, Abhayaratna, W., additional, Prior, D., additional, O’Donnell, D., additional, Kistler, P., additional, Bohra, S., additional, and Krum, H., additional
- Published
- 2009
- Full Text
- View/download PDF
17. Inflammatory bowel disease after 10 years: A single unit's experience
- Author
-
Cullen, G, primary, Brennan, L, additional, Bohra, S, additional, Keegan, D, additional, Mulcahy, H, additional, and O'Donoghue, D, additional
- Published
- 2005
- Full Text
- View/download PDF
18. Airborne fluorescence imaging of the ocean mixed layer.
- Author
-
Terray, E.A., Ledwell, J.R., Sundermeyer, M.A., Donoghue, T., Bohra, S., Cunningham, A.G., LaRoque, P.E., Lillycrop, W.J., and Wiggins, C.E.
- Published
- 2005
- Full Text
- View/download PDF
19. Lettuce seed germination: Prevention of thermodormancy by 2-chloroethanephosphonic acid (ethrel)
- Author
-
Harsh, G. D., Vyas, O. P., Bohra, S. P., and Sankhla, N.
- Published
- 1973
- Full Text
- View/download PDF
20. Guaran: A Novel Polysaccharide for Racemate Resolution
- Author
-
Mathur, R., primary, Bohra, S., additional, Narang, C. K., additional, and Mathur, N. K., additional
- Published
- 1992
- Full Text
- View/download PDF
21. Modeling of Si-QD Solar Cell in MATLAB.
- Author
-
Bohra, S. S. and Panchal, A. K.
- Subjects
SOLAR cells ,SOLAR energy ,PERMEABLE reactive barriers ,THICKNESS measurement ,QUANTUM tunneling ,SILICON - Abstract
In this paper, the modeling and analysis of single bi-layer Si-QD solar cell is addressed. The modeling of solar cell is done in MATLAB. The photo currents are calculated for various Si-QD diameters like 2.5, 3, 3.5 and 4 nm and SiO
2 barrier layer thicknesses like 2.5, 2 and 1.5 nm. It has been observed that with the Si-QD diameter, the photo-current increases. On the other hand, photo-current varies conversely with barrier layer thickness due low carrier tunneling probability through barrier. [ABSTRACT FROM AUTHOR]- Published
- 2013
22. Acute upper gastrointestinal haemorrhage and colitis: an unusual presentation of Wegener's granulomatosis.
- Author
-
Steele, C, Bohra, S, Broe, P, and Murray, F E
- Published
- 2001
- Full Text
- View/download PDF
23. Biochemical Changes in Acacia Senegal due to Bioinnoculants
- Author
-
Bohra, Sonia
- Published
- 2013
- Full Text
- View/download PDF
24. Participatory renovation, extension, modernisation & irrigation management in EC aided minor irrigation projects in Orissa
- Author
-
Rao, Sisir, Panigrahi, Narayan, and Bohra, Sanatan Dal
- Published
- 2008
25. Comparison and prediction of the extent of lesion of oral squamous cell carcinoma
- Author
-
Minal Chaudhary, Bohra, S., Gupta, R., and Patil, S.
26. High Power Klystron Amplifier for Troposcatter Communication System
- Author
-
Rao, E. Bhagiratha, primary, Bohra, S. K., additional, Sehgal, Y. P., additional, and Sharma, D. K., additional
- Published
- 1977
- Full Text
- View/download PDF
27. Airborne fluorescence imaging of the ocean mixed layer
- Author
-
Terray, E.A., primary, Ledwell, J.R., additional, Sundermeyer, M.A., additional, Donoghue, T., additional, Bohra, S., additional, Cunningham, A.G., additional, LaRoque, P.E., additional, Lillycrop, W.J., additional, and Wiggins, C.E., additional
- Full Text
- View/download PDF
28. Wastewater Surveillance for Influenza A Virus and H5 Subtype Concurrent with the Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in Cattle and Poultry and Associated Human Cases - United States, May 12-July 13, 2024.
- Author
-
Louis S, Mark-Carew M, Biggerstaff M, Yoder J, Boehm AB, Wolfe MK, Flood M, Peters S, Stobierski MG, Coyle J, Leslie MT, Sinner M, Nims D, Salinas V, Lustri L, Bojes H, Shetty V, Burnor E, Rabe A, Ellison-Giles G, Yu AT, Bell A, Meyer S, Lynfield R, Sutton M, Scholz R, Falender R, Matzinger S, Wheeler A, Ahmed FS, Anderson J, Harris K, Walkins A, Bohra S, O'Dell V, Guidry VT, Christensen A, Moore Z, Wilson E, Clayton JL, Parsons H, Kniss K, Budd A, Mercante JW, Reese HE, Welton M, Bias M, Webb J, Cornforth D, Santibañez S, Soelaeman RH, Kaur M, Kirby AE, Barnes JR, Fehrenbach N, Olsen SJ, and Honein MA
- Subjects
- Animals, Humans, Cattle, United States epidemiology, Influenza A virus isolation & purification, Cattle Diseases epidemiology, Cattle Diseases virology, Wastewater-Based Epidemiological Monitoring, Poultry Diseases epidemiology, Poultry Diseases virology, Disease Outbreaks, Wastewater virology, Influenza, Human epidemiology, Influenza, Human virology, Poultry, Influenza A Virus, H5N1 Subtype isolation & purification, Influenza in Birds epidemiology, Influenza in Birds virology
- Abstract
As part of the response to the highly pathogenic avian influenza A(H5N1) virus outbreak in U.S. cattle and poultry and the associated human cases, CDC and partners are monitoring influenza A virus levels and detection of the H5 subtype in wastewater. Among 48 states and the District of Columbia that performed influenza A testing of wastewater during May 12-July 13, 2024, a weekly average of 309 sites in 38 states had sufficient data for analysis, and 11 sites in four states reported high levels of influenza A virus. H5 subtype testing was conducted at 203 sites in 41 states, with H5 detections at 24 sites in nine states. For each detection or high level, CDC and state and local health departments evaluated data from other influenza surveillance systems and partnered with wastewater utilities and agriculture departments to investigate potential sources. Among the four states with high influenza A virus levels detected in wastewater, three states had corresponding evidence of human influenza activity from other influenza surveillance systems. Among the 24 sites with H5 detections, 15 identified animal sources within the sewershed or adjacent county, including eight milk-processing inputs. Data from these early investigations can help health officials optimize the use of wastewater surveillance during the upcoming respiratory illness season., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. John Anderson reports support from the Council of State and Territorial Epidemiologists (CSTE) for travel to the 2023 Advanced Molecular Detection Days and the 2024 Advanced Molecular Detection Academy. Alexandria B. Boehm reports institutional support from the Sergey Brin Family Foundation and grant support from the U.S. National Science Foundation for research coordination network for wastewater-based epidemiology and from the Sloan Foundation for public health partnerships and wastewater-based epidemiology, and membership on the state of California wastewater-based epidemiology committee of the State Water Board. Ruth Lynfield reports support from the Infectious Diseases Society of America, CSTE, the National Foundation for Infectious Diseases, and the American Academy of Pediatrics to attend state epidemiology meetings, ID Week, CSTE Board meetings and CSTE annual conference, National Foundation for Infectious Diseases meeting, and the Committee on Infectious Diseases meeting. Marlene K. Wolfe reports a subaward gift to Stanford University, a grant from the Rockefeller Foundation for implementation of wastewater-based epidemiology in Bangladesh and Ghana and a subaward from Ceres Nanosciences (subaward from National Institutes of Health funding) for wastewater monitoring research, and support from the American Society of Microbiology for an invited talk at a conference. No other potential conflicts of interest were disclosed.
- Published
- 2024
- Full Text
- View/download PDF
29. Argon plasma coagulation-an effective treatment for solitary rectal ulcer syndrome: A single-center experience from western India.
- Author
-
Shah A, Bohra S, and Desai S
- Subjects
- Adult, Aged, Female, Gastrointestinal Hemorrhage etiology, Humans, India, Male, Middle Aged, Rectal Diseases complications, Syndrome, Treatment Outcome, Ulcer complications, Wound Healing, Argon Plasma Coagulation, Gastrointestinal Hemorrhage therapy, Rectal Diseases therapy, Ulcer therapy
- Abstract
Background and Aim: Solitary rectal ulcer syndrome (SRUS) is an uncommon benign disorder of defecation. Management of ulcers is usually unsatisfactory with conventional treatment (laxatives, behavioral therapy, biofeedback, topical treatments, and surgery). Studies on the effectiveness of argon plasma coagulation (APC) for SRUS refractory to conventional treatment is lacking. The aim of the study was to examine the effect of APC with conventional therapy in controlling bleeding and healing of refractory SRUS., Methods: Fourteen patients of refractory SRUS diagnosed on clinical, colonoscopic, and histological findings, refractory to conventional therapy, were offered multiple sessions of APC in addition to conventional treatment. All patients were followed up to determine bleeding control and ulcer healing., Results: Fourteen patients with a mean duration of symptoms of 9.21 ± 6.94 months were included. All the patients were advised to have a high intake of fluids and laxatives and to undergo biofeedback in addition to the APC. Lesions were located anteriorly (66%), circumferentially (25%), and posteriorly (9%). Mean follow-up duration was 7 months (3 to 12 months). APC enabled bleeding control in all the patients (100%), complete healing of ulcer in 71% (10 patients), and reduction in ulcer size to less than 50% of the initial size in the remaining 29% patients. None of the patients had any procedure-related complications like bowel perforation, infections, or fistula formation., Conclusions: APC with conventional therapy is effective in controlling bleeding and healing in SRUS refractory to conventional treatment.
- Published
- 2021
- Full Text
- View/download PDF
30. Exploring behaviors, treatment beliefs, and barriers to oral chemotherapy adherence among adult leukemia patients in a rural outpatient setting.
- Author
-
Lea CS, Bohra S, Moore T, Passwater C, and Liles D
- Subjects
- Academic Medical Centers statistics & numerical data, Administration, Oral, Adult, Humans, North Carolina, Psychometrics instrumentation, Rural Population statistics & numerical data, Ambulatory Care statistics & numerical data, Antineoplastic Agents administration & dosage, Health Behavior, Health Knowledge, Attitudes, Practice, Leukemia, Myeloid drug therapy, Medication Adherence statistics & numerical data, Multiple Myeloma drug therapy
- Abstract
Objective: Adherence to oral chemotherapy is essential for patients with chronic myeloid leukemia (CML) and multiple myeloma (MM) to remain in remission. Few studies have used a Likert-type scale to measure medication adherence in CML and MM patients. We applied a validated treatment adherence tool, the ASK-12 (Adherence Starts with Knowledge
® ) survey, which assessed inconvenience and forgetfulness, treatment beliefs, and medication-taking behaviors recorded on a five-point Likert-type scale at two visits., Results: A medication adherence survey was administered to 42 newly diagnosed or pre-existing CML or MM patients at two outpatient oncology clinics affiliated with an academic medical center in rural eastern North Carolina. Thirty-one patients completed surveys at visit 1 and visit 2 (median 4.5 months apart). Most patients were treated for MM (65%), were non-Hispanic black (68%) and female (58%). Within subscales, mean adherence scores decreased between visits, signaling better adherence. Overall, visit scores were correlated (0.63, p = 0.001). Forgetting to take medication sometimes was the most common reason for non-adherence. Medication costs were not a barrier for MM patients. Greater patient-provider informed decision-making was identified as an opportunity for quality improvement among CML patients. The ASK-12 survey provided a strategy to obtain robust information on medication adherence.- Published
- 2018
- Full Text
- View/download PDF
31. Cardiac Amyloidosis, An Infiltrative Heart Disease Presenting as Arrhythmia-A Case Report.
- Author
-
Magesh B, Kadeli D, Bohra S, Krishnaprasath V, and Keshava R
- Abstract
Cardiac amyloidosis is a manifestation of amyloidosis which is a multisystem disorder. This is difficult to diagnose, rare disease which eventually leads to the mortality. Diagnosis requires a high index of clinical suspicion along with echocardiographic clues like, diastolic dysfunction, bi-atrial enlargement and ventricular thickening. Treatment is mainly supportive with disappointing outcomes. We present a case of systemic amyloidosis with negative congo red staining, presenting with predominantly cardiac features.
- Published
- 2017
- Full Text
- View/download PDF
32. Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study.
- Author
-
Agarwal R, Chaudhary M, Bohra S, and Bajaj S
- Abstract
Objectives: Natural killer (NK) cells are important effector lymphocytes. NK cells are considered to represent innate immune system. NK cells target and kill aberrant cells such as virally infected and tumorigenic cells. The purpose of this study was to assess the expression of CD57 in oral squamous cell carcinoma (OSCC) and to correlate the expression of CD57 with 3 years survival in patients with OSCC., Materials and Methods: About 100 histopathologically diagnosed cases of OSCC of various grades were divided into two groups, i.e., Group I (dead patients) and Group II (live patients) from the archives of Department of Oral Pathology and Microbiology. CD57 was detected in these tissues by immunohistochemistry., Result: The results were analyzed using Spearman's correlation coefficient and students unpaired t-test. The mean CD57 labeling index in Group II was significantly higher than that found in Group I (P = 0.000). There was a significant correlation (P = 0.00) in the mean CD57 levels between Groups I and II and prognosis of patient., Conclusion: CD57 could be a good prognostic marker for OSCC patients.
- Published
- 2016
- Full Text
- View/download PDF
33. Solvent resistant chitosan/poly(ether-block-amide) composite membranes for pervaporation of n-methyl-2-pyrrolidone/water mixtures.
- Author
-
Prasad NS, Moulik S, Bohra S, Rani KY, and Sridhar S
- Subjects
- Chitosan chemistry, Diffusion, Hydrodynamics, Permeability, Pressure, Tensile Strength, Volatilization, Chitosan analogs & derivatives, Membranes, Artificial, Polymers chemistry, Pyrrolidinones chemistry, Water chemistry
- Abstract
A novel composite barrier comprising of hydrophilic and solvent resistant chitosan (CS) membrane on porous solvent resistant poly(ether-block-amide) (PEBA-2533) substrate was synthesized for pervaporation (PV) based dehydration of the polar aprotic n-methyl-2-pyrolidone (NMP) green solvent. The composite barrier was crosslinked with tetraethyl orthosilicate (TEOS) to control swelling and enhance selectivity. Operating parameters such as feed water concentration, permeate pressure and membrane thickness were varied to assess membrane flux and selectivity. A two-dimensional finite element method (FEM) model was developed to predict the concentration profile within the membrane through computational fluid dynamics (CFD). On the basis of complete mixing experiments, a numerical simulation was performed to predict membrane area requirement and exit streams' compositions for commercial pervaporation units operated in plug flow mode. Both unmodified chitosan and tetraethyl orthosilicate crosslinked composite membranes successfully separated feed mixture containing 4.6 wt% water by exhibiting water fluxes of 0.024 and 0.019 kg/m(2)h, whereas the corresponding selectivities were found to be as high as 182 and 225, respectively., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
34. A survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society.
- Author
-
Shenthar J, Bohra S, Jetley V, Vora A, Lokhandwala Y, Nabar A, Naik A, Calambur N, and Gupta SB
- Subjects
- Aged, Arrhythmias, Cardiac epidemiology, Female, Humans, India, Male, Middle Aged, Morbidity trends, Retrospective Studies, Arrhythmias, Cardiac therapy, Defibrillators, Implantable statistics & numerical data, Electrocardiography, Pacemaker, Artificial statistics & numerical data, Registries, Societies, Medical statistics & numerical data, Surveys and Questionnaires
- Abstract
Background: There is limited data regarding the demographics and type of cardiac implantable electronic device (CIED) in India., Aim: The aim of this survey was to define trends in CIED implants, which included permanent pacemakers (PM), intracardiac defibrillators (ICD), and cardiac resynchronization therapy pacemakers and defibrillators (CRT-P/D) devices in India., Methods: The survey was the initiative of the Indian Society of Electrocardiology and the Indian Heart Rhythm Society. The type of CIED used, their indications, demographic characteristics, clinical status and co-morbidities were collected using a survey form over a period of 1 year., Results: 2117 forms were analysed from 136 centers. PM for bradyarrhythmic indication constituted 80% of the devices implanted with ICD's and CRT-P/D forming approximately 10% each. The most common indication for PM implantation was complete atrio-ventricular block (76%). Single chamber (VVI) pacemakers formed 54% of implants, majority in males (64%). The indication for ICD implantation was almost equal for primary and secondary prevention. A single chamber ICD was most commonly implanted (65%). Coronary artery disease was the etiology in 58.5% of patients with ICD implants. CRT pacemakers were implanted mostly in patients with NYHA III/IV (82%), left ventricular ejection fraction <0.35 (88%) with CRT-P being most commonly used (57%)., Conclusion: A large proportion of CIED implants in India are PM for bradyarrhythmic indications, predominantly AV block. ICD's are implanted almost equally for primary and secondary prophylaxis. Most CRT devices are implanted for NYHA Class III. There is a male predominance for implantation of CIED., (Copyright © 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
35. Clinicopathological significance of Melkersson-Rosenthal syndrome.
- Author
-
Bohra S, Kariya PB, Bargale SD, and Kiran S
- Subjects
- Adolescent, Cheilitis pathology, Diagnosis, Differential, Female, Humans, Cheilitis etiology, Edema etiology, Gingival Diseases etiology, Melkersson-Rosenthal Syndrome diagnosis, Tongue, Fissured etiology
- Abstract
Melkersson-Rosenthal syndrome (MRS) classically shows a triad of orofacial swelling, fissured tongue and facial palsy, more commonly the oligosymptomatic form. The orofacial swelling is characterised by swollen reddish-brown non-pruritic lips and facial oedema. In one-third to one half of patients, fissured tongue is seen, which also aids in diagnosis. The histological finding of MRS includes non-caseating, sarcoidal granulomas, but their absence does not exclude the diagnosis. All these findings together form a basis for a cautious search for confrontational reasons for the symptom complex of MRS., (2015 BMJ Publishing Group Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
36. Pervaporation performance of PPO membranes in dehydration of highly hazardous mmh and udmh liquid propellants.
- Author
-
Moulik S, Kumar KP, Bohra S, and Sridhar S
- Subjects
- Algorithms, Calorimetry, Differential Scanning, Membranes, Artificial, Microscopy, Electron, Scanning, Models, Molecular, Temperature, Water chemistry, 1,2-Dimethylhydrazine chemistry, Aerosol Propellants chemistry, Hazardous Substances chemistry, Hydrazines chemistry, Monomethylhydrazine chemistry, Phenols chemistry, Polymers chemistry
- Abstract
Polyphenylene oxide (PPO) membranes synthesized from 2,6-dimethyl phenol monomer were subjected to pervaporation-based dehydration of the highly hazardous and hypergolic monomethyl hydrazine (MMH) and unsymmetrical dimethyl hydrazine (UDMH) liquid propellants. Membranes were characterized by TGA, DSC and SEM to study the effect of temperature besides morphologies of surface and cross-section of the films, respectively. Molecular dynamics (MD) simulation was used to study the diffusion behavior of solutions within the membrane. CFD method was employed to solve the governing mass transfer equations by considering the flux coupling. The modeling results were highlighted by the experimental data and were in good agreement. High separation factors (35-70) and reasonable water fluxes (0.1-0.2 kg/m(2)h) were observed for separation of the aqueous azeotropes of MMH (35 wt%) and UDMH (20 wt%) and their further enrichment to >90% purity. Effect of feed composition, membrane thickness and permeate pressure on separation performance of PPO membranes were investigated to determine optimum operating conditions., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
37. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
- Author
-
Chaudhary M, Bajaj S, Bohra S, Swastika N, and Hande A
- Abstract
Introduction: Oral submucous fibrosis (OSMF) is a precancerous condition predominantly seen in people of Asian descent. About 7-12% OSMF patients develop oral squamous cell carcinoma (OSCC). Morphological features of OSMF especially fibrosis suggests a possibility of the hypoxic environment in diseased tissues. Oral cancer usually develops from hyperplasia through dysplasia to carcinoma. Neovascularization and increased glycolysis, represent adaptations to a hypoxic microenvironment that are correlated with tumor invasion and metastasis. The adaptation of cells to hypoxia appears to be mediated via hypoxia inducible factor-1α (HIF-1α). HIF-1α is said to be associated with malignant transformation of epithelium in other sites. It appears that HIF-1α plays a significant role in both prostate and cervical carcinogenesis at early stages. We hypothesize that progression of OSMF and malignant transformation in the background of fibrosis mediates via HIF-1α either by up- or down-regulation of various such molecules. Therefore, the main objective of this study was to investigate the relationship between the expression of HIF-1α in OSMF, OSCC and OSCC with OSMF., Aim: To investigate the relationship between the expression of HIF-1α in OSMF, OSCC and OSCC with OSMF., Materials and Methods: The study group consists of histopathologically diagnosed 20 cases of OSCC, oral submucous fibrosis and OSCC with OSMF each. The immunohistochemistry was carried out on neutral buffered formalin-fixed paraffin-embedded tissue sections by using the monoclonal antibody of HIF-1α., Results: A rise in the expression of HIF-1α from OSMF to OSCC to OSCC with OSMF is observed.
- Published
- 2015
- Full Text
- View/download PDF
38. Dimensional change in soft tissues with complete dental prosthesis and its effect on airway space and natural head position.
- Author
-
Padmanabhan TV, Banu RF, Mahalakshmi A, Aziz A, Bohra S, and Kumar VA
- Subjects
- Aged, Female, Head anatomy & histology, Humans, Larynx anatomy & histology, Male, Middle Aged, Models, Dental, Palate, Soft anatomy & histology, Prosthesis Fitting, Tongue anatomy & histology, Cephalometry, Denture Design, Denture, Complete, Head diagnostic imaging, Larynx diagnostic imaging, Palate, Soft diagnostic imaging, Tongue diagnostic imaging
- Abstract
Background: Insertion of the intraoral prosthesis causes deflection of the tongue, soft palate affecting the patency of the airway., Aims: To evaluate the cephalometric soft tissue variation in tongue, soft palate, and its effect on posterior airway space in edentulous patients with the insertion of the denture., Settings and Design: Randomized controlled trial., Materials and Methods: Complete denture (CD) prosthesis was fabricated for first time denture wearers comprising 22 males and 18 females within the age range of 50-65 years. Lateral skull radiographs were taken for each of the subjects in their resting position without CDs (T0), with CDs (T1) at least 1-week postinsertion and after 6 months of usage (T2), respectively. The reference points, lines, and angles on the cephalometric films were used to evaluate the position or inclination of the head, variations in tongue position and length, the changes in the anteroposterior dimension of the soft palate, and posterior airway space variations. Intra-investigator error variance was not found to be statistically significant (P < 0.05)., Statistical Analysis Used: Using Statistical Package for the Social Sciences (SPSS) v16.0 the significant difference in the paired samples (without CD and with CD) was found using the paired t-test. The probability value P = 0.05 is considered as a significant level., Results: On comparison of T1 and T0, the heads were more extended with the downward position of the tongue with an increase in its length and the posterior airway space was decreased in T1. Significant differences in values were not observed between T1 and T2., Conclusions: With CDs, the change in airway space was related to alteration in soft palate and tongue dimension. There were no changes in dimension at 6 months follow-up.
- Published
- 2015
- Full Text
- View/download PDF
39. Evidence based demonstration of the concept of 'field cancerization' by p53 expression in mirror image biopsies of patients with oral squamous cell carcinoma - an immunohistochemical study.
- Author
-
Hande AH, Mohite DP, Chaudhary MS, Patel M, Agarwal P, and Bohra S
- Subjects
- Biopsy, Carcinoma, Squamous Cell diagnosis, Demography, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mouth Neoplasms diagnosis, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell pathology, Evidence-Based Medicine, Mouth Neoplasms metabolism, Mouth Neoplasms pathology, Tumor Suppressor Protein p53 metabolism
- Abstract
Objective: The main rationale for treatment failure and death of the patients with oral squamous cell carcinoma (OSCC) is loco-regional recurrence, development of second primary tumor (SPT) and metastasis, which could be well explained by concept of field cancerization. Identification of patients at high risk for development of SPT is an important part of research for cancer management. This study was designed keeping this aspect in mind and utilizing the increased expression of p53 as an indicator of existence of altered fields in mirror image biopsies of OSCC patients., Design: Forty clinically diagnosed oral cancer patients were included in the study. Biopsy tissue samples from clinically diagnosed oral cancer patients (Group A) and the mirror image, clinically normal looking mucosa at corresponding contralateral anatomical site (Group B) were studied for histopathological evaluation and p53 immunoexpression., Results: Tissue alterations were observed in Groups A and B. There was statistically significant (chi-square value - 126.6, p=0.0001) difference in grades of epithelial dysplasia and p53 immunoexpression in Group B. Spearman's Rank Correlation Coefficient shows non-significant positive correlation between epithelial dysplasia and p53 (r=0.28, p=0.05) in Group B., Conclusions: Evidence of presence of field cancerization, evaluated by histopathological alterations and enhanced p53 expression was observed in mirror image biopsies of OSCC patients. This could predict the altered state of oral mucosa secondary to carcinogen exposure. The realization of a genetically altered field as a cancer risk factor provides a new paradigm. It would be prudent to keep these patients under close observation and to advice them chemotherapeutic regimes.
- Published
- 2015
40. Removal of chromium by some multipurpose tree seedlings of Indian thar desert.
- Author
-
Mathur N, Singh J, Bohra S, Bohra A, and Vyas A
- Subjects
- Citric Acid metabolism, Citric Acid pharmacology, Desert Climate, India, Plant Leaves metabolism, Plant Roots metabolism, Plant Shoots metabolism, Salvadoraceae metabolism, Salvadoraceae microbiology, Species Specificity, Terminalia metabolism, Terminalia microbiology, Trees microbiology, Carcinogens, Environmental metabolism, Chromium metabolism, Mycorrhizae metabolism, Seedlings metabolism, Trees metabolism
- Abstract
An experiment was conducted to study the potential of chromium (Cr) phytoaccumulatory capabilities of four tree species viz., Anogeissus latifolia, Terminalia arjuna, Tecomella undulata, and Salvadora persica Possibility of enhancement of Cr uptake by citric acid and vesicular arbuscular mycorrhizal fungi (VAM) amendments were also tried. Cr is a major pollutant of the environment. Chromium can exist in oxidation states from III to VI, but the most stable and common forms of Cr are trivalent and hexavalent species. Cr(VI) was more toxic to the tree growth in terms of collar diameter (CD) increment in all the tree species than Cr(lll). Roots accumulated more Cr than shoots in all the tree species. There was more than 10 fold increase in root Cr content in comparison with shoot Cr content in all the trees at all the concentration of Cr and all sources of Cr. Citric acid significantly increased the Cr content in the tissues of roots in all the species under both speciation of Cr. The highest increase in Cr content brought by 20 mM citric acid addition was in A. latifolia Results suggest that Anogeissus latifolia is a potential Cr accumulator with citric acid as soil amendment.
- Published
- 2010
- Full Text
- View/download PDF
41. Holding but not restriction.
- Author
-
Kudoh H, Satoh K, Bohra S, Yamamoto T, Fujii M, and Sasaki H
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Manikins, Anxiety etiology, Anxiety therapy, Dementia complications, Physical Therapy Modalities, Relaxation Therapy methods, Restraint, Physical instrumentation
- Published
- 2010
- Full Text
- View/download PDF
42. Cardiotoxicity of verapamil in renal failure: a case report and review of the literature.
- Author
-
Jadhav PP and Bohra S
- Abstract
We present a case of a 76-year-old diabetic patient on verapamil with undiagnosed renal failure presenting with collapse and severe life threatening bradyarrhythmias. She responded well to inotropic support and calcium supplementation.
- Published
- 2009
- Full Text
- View/download PDF
43. Medication use in early pregnancy: a study in a teaching hospital in Western Nepal.
- Author
-
Sarkar C, Das B, Datta A, and Bohra S
- Subjects
- Female, Hospitals, Teaching, Humans, Nepal, Pregnancy, Pregnancy Trimester, First, Prenatal Care, Drug Utilization Review, Practice Patterns, Physicians' statistics & numerical data, Pregnancy Complications drug therapy
- Abstract
This study explored the extent of drug use in early pregnancy (first trimester of pregnancy) in Nepalese women in the setting of a large teaching hospital in western Nepal.
- Published
- 2007
- Full Text
- View/download PDF
44. A prospective analysis of inpatient consultations to a gastroenterology service.
- Author
-
Bohra S, Byrne MF, Manning D, Smyth C, Patchett SE, and Murray FE
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Ireland, Male, Middle Aged, Prospective Studies, Gastroenterology statistics & numerical data, Inpatients, Referral and Consultation statistics & numerical data
- Abstract
The provision of a formal consultation service for inpatients between subspecialists is little studied. We prospectively surveyed the pattern of inpatient consultations from hospital-based generalists and surgeons to the gastroenterology (GI) service for inpatients in a large urban teaching hospital over a 5 month period. There are two GI consultants/attendings and five GI registrars/fellows on the service. A formal consultation is made by the requesting team to the GI service using the hospital computer network. All referrals over a 5 month period were prospectively analysed. 242 consecutive inpatient referrals were sent to the GI service over 5 months. Average age was 56 years, 48.8% males. 32 consultants/attendings from other disciplines sent referrals. Most patients were seen within one working day. Urgent referrals were seen without delay. The commonest reasons for referral were abdominal pain (15.8%), percutaneous endoscopic gastrostomy (PEG) tube insertion (13.6%), diarrhoea (12.8%), abnormal liver blood tests (10%), nausea and vomiting (8.2%), anaemia (6.2%), and melaena (4.9%). Iatrogenic diseases accounted for 6.2% of consultations. Ongoing patient care was assumed by the GI team in 9.5% of referrals. 15.3% required a second consultation visit before discharge. 22.7% of referrals were followed in the GI outpatients' clinic after discharge. 51.2% underwent an endoscopic procedure. 13.6% of referrals were for PEG tube insertion. A quarter of these were considered unsuitable for immediate PEG tube insertion. Subspecialty consultation provides an expert opinion, encourages discussion and learning, and improves patient care. In our experience, the provision of specialist advice and reassurance often speeded up a patient's work-up and expedited discharge. However, evaluating referral patients and subsequently providing ongoing inpatient and outpatient care and provision of endoscopy for these referrals contributes significantly to the workload of the GI service.
- Published
- 2003
45. A study of drug use during pregnancy in a teaching hospital in western Nepal.
- Author
-
Das B, Sarkar C, Datta A, and Bohra S
- Subjects
- Adolescent, Adult, Data Collection, Drug Utilization trends, Female, Humans, Nepal epidemiology, Outpatients, Practice Patterns, Physicians', Pregnancy, Drug Utilization statistics & numerical data, Hospitals, Teaching, Pregnancy Complications drug therapy
- Abstract
Information on the use of drugs during pregnancy is scarce and rather anecdotal. Careful consideration of the benefit to the mother and the risk to the fetus is required when prescribing drugs during pregnancy. The aim of this study was to gain knowledge on this issue in western Nepal. 2156 prescriptions of pregnant women were collected at random from the antenatal care (ANC) in obstetrics out-patient department (OPD) at Manipal Teaching Hospital (MTH), Nepal and analyzed for this study. The mean maternal age and hemoglobin concentration were 25 years and 12.21 g/dl, respectively. Twenty-three percent women attended obstetric OPD due to maternal disorders other than routine ANC (77%). Problem oriented drug use was due to nausea/vomiting (4.7%), dyspepsia (3.1%), and per vaginal spotting/bleeding (3.4%), mainly. Most of the women got 2-3 drugs and commonly included nutritional supplementation and tetanus toxoid. The average number of drugs/prescription was 2.00, 15.37% and 64.8% drugs were prescribed by generic name and as fixed dose combinations, respectively. The most commonly prescribed drugs were nutritional supplements like iron, folate, calcium, vitamins (72.8%), followed by tetanus toxoid (12.4%), gastrointestinals (5%), antimicrobials (4.6%), etc. Though, the selection of drugs was rational in most of the cases, some anomalies were observed and discussed with the clinicians. Our data reflect the general extent and prescribing pattern for those Nepalese pregnant women attending hospital in western Nepal.
- Published
- 2003
- Full Text
- View/download PDF
46. Evaluation of communication skills of physicians about asthma.
- Author
-
Singh V, Khandelwal R, Bohra S, Gupta R, and Gupta BS
- Subjects
- Asthma diagnosis, Communication, Female, Health Care Surveys, Humans, India, Male, Practice Patterns, Physicians', Quality of Health Care, Surveys and Questionnaires, Asthma therapy, Attitude of Health Personnel, Clinical Competence, Physician-Patient Relations
- Abstract
Objective: Communication skills in medical practice are important. To assess the communication skills of physicians about asthma, we undertook this study., Methods: One thousand four hundred and twenty one physicians attending the annual conference of association of physicians of India volunteered to participate in the study. They were divided into three categories. 'Teachers' group 1, (n = 131), 'Clinicians', group 2, (n = 951) and 'Students' group 3, (n = 339). Questionnaire containing ten most frequently asked questions by asthmatic patients were given to the physicians. A panel of three patients assessed the replies of these question and graded them as 'Convincing', 'Just convincing' and 'Not convincing'., Results: Replies of only 2% of physicians were graded as convincing, 15.6% just convincing and 82.4 as not convincing. Among group 1 none gave a convincing reply while replies of 2.2% of group 2 and 2.4% of group 3 were graded as convincing. The difference in results was not significant statistically on comparing the three groups (p > 0.1)., Conclusions: Communication skills are the integral part of patient care and management. Our study demonstrated lack of effective communication skills among physicians.
- Published
- 2002
47. General hospital psychiatric clinic versus mental hospital setting: a study of socio-demographic variables in a novel experience.
- Author
-
Bhargava SC, Bohra SP, and Purohit DR
- Abstract
A retrospective analysis of data showed that patients in general stayed for shorter duration in general hospital psychiatric clinic than in mental hospital.
- Published
- 1981
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.